GLS-5700

BIOLOGICAL2 trials

Sponsors

GeneOne Life Science, Inc.

Conditions

HealthyZika

Phase 1

GLS-5700 in Dengue Virus-Naïve Adults

CompletedNCT02809443

GeneOne Life Science, Inc.Healthy

Start: 2016-07-31End: 2017-12-31Updated: 2024-12-24

GLS-5700 in Dengue Virus Seropositive Adults

CompletedNCT02887482

GeneOne Life Science, Inc.Healthy, Zika

Start: 2016-08-31End: 2018-06-30Updated: 2022-01-20

Related Papers

Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine.

2021-09-01224 citations